Evidence map›Paper›PMID 25416812›Full record

ArticleThe Journal of infectious diseases2015

Influenza vaccine effectiveness in households with children during the 2012-2013 season: assessments of prior vaccination and serologic susceptibility.

Suzanne E Ohmit, Joshua G Petrie, Ryan E Malosh, Alicia M Fry, Mark G Thompson, Arnold S Monto

Abstract read
In one paragraph

Article in The Journal of infectious diseases, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 59 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
59citing papers in PubMed, 3 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

59 citing papers in PubMed, 3 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Trial
  5. Trial
  6. Trial
  7. Effect of Previous-Year Vaccination on the Efficacy, Immunogenicity, and Safety of High-Dose Inactivated Influenza Vaccine in Older Adults.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2016
    Trial
  8. Trial
  9. Review
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Effectiveness of Influenza Vaccines in the HIVE Household Cohort Over 8 Years: Is There Evidence of Indirect Protection?Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2021
    Article
  17. Simple models to include influenza vaccination history when evaluating the effect of influenza vaccination.Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin · 2021
    Article
  18. Article
  19. [High-dose trivalent influenza vaccine. Efficacy and effectiveness].Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia · 2020
    Review
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

6 authors.

Suzanne E OhmitDepartment of Epidemiology, University of Michigan School of Public Health, Ann Arbor.
Joshua G PetrieDepartment of Epidemiology, University of Michigan School of Public Health, Ann Arbor.
Ryan E MaloshDepartment of Epidemiology, University of Michigan School of Public Health, Ann Arbor.
Alicia M FryInfluenza Division, Centers for Disease Control and Prevention, Atlanta, Georgia.
Mark G ThompsonInfluenza Division, Centers for Disease Control and Prevention, Atlanta, Georgia.
Arnold S MontoDepartment of Epidemiology, University of Michigan School of Public Health, Ann Arbor.

Funding

Core_plus_Option_A_B_Proposal for Influenza Vaccine Effectiveness ResearchU01IP000474 · IP · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI MONTO, ARNOLD S · 2011 to 2015
$6.2M
Household Studies of Influenza and Other Respiratory Viruses - Supplement: EV D68 SurveillanceR01AI097150 · NIAID · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI MONTO, ARNOLD S, OHMIT, SUZANNE · 2012 to 2015
$2.0M
NCIRD CDC HHS U01 IP000474NCIRD CDC HHS U01IP000474NCIRD CDC HHS U01 IP001034NIAID NIH HHS R01 AI097150
6 · The paper itself

Abstract

backgroundThere are recognized needs to identify determinants of influenza vaccine effectiveness (VE), including the effect of repeated annual vaccination.

methodsWe recruited 321 households with 1426 members, including 833 children, and followed them during the 2012-2013 influenza season; specimens were collected from subjects with reported acute respiratory illnesses. We estimated the effectiveness of documented influenza vaccination in preventing laboratory-confirmed influenza, using adjusted Cox proportional hazards models. Antibody titers in a subset of subjects were determined by a hemagglutination inhibition assay to determine the subjects' preseason susceptibility to influenza.

resultsInfluenza was identified in 76 (24%) households and 111 (8%) individuals. VE point estimates indicated significant protection in adults (48%; 95% confidence interval [CI], 1%-72%), similar protection in children aged 9-17 years (49%; 95% CI, -16% to 78%), but no evidence of effectiveness in children aged <9 years (-4%; 95% CI, -110% to 49%). Lower VE was observed in those vaccinated in both the current and prior seasons, compared with those vaccinated in the current season only; susceptibility titers against type A but not type B were consistent with this observation. Residual protection from vaccination in the prior season was indicated by both VE and serologic results.

conclusionsPrior vaccination appears to modify VE by both residual protection and reduced vaccine response.

Indexed as

AdolescentAdultAntibodies, ViralChildFamily CharacteristicsFemaleHemagglutination Inhibition TestsHumansInfantInfluenza, HumanInfluenza VaccinesMaleMiddle AgedTreatment OutcomeYoung AdultAntibodies, ViralInfluenza Vaccineshouseholds with childreninfluenzaserologic susceptibilityvaccine effectiveness

Identifiers

PMID25416812
PMCPMC4462665

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.